3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
CNS
5
Interventions
lutetium Lu 177 dotatate
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
entrectinib
1
copper dotatate CU-64
1
cabozantinib
1
X-Rays
1
Specimen Handling
1
Phantoms, Imaging
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
TIC10 compound
×
NET
×
Clear all
No trials found.